Skip to main content

Written question asked by Baroness McIntosh of Pickering (Conservative) on Thursday, 22 March 2001, in the House of Commons. It was due for an answer on Thursday, 29 March 2001. It was answered by John Denham (Labour) on Thursday, 29 March 2001 on behalf of the Department of Health.


Dept of Health

Question
To ask the Secretary of State for Health, what assessment was made of the long-term offset in savings for primary care resources prior to the issuing of NICE guidance on Orlistat for the treatment of obesity.
Answer

Miss McIntosh: To ask the Secretary of State for Health what assessment was made of the long-term offset in savings for primary care resources prior to the issuing of NICE guidance on orlistat for the treatment of obesity. [155653] Mr. Denham: The National Institute for Clinical Excellence recognised the link between obesity and other diseases, but concluded that the long-term savings from treating the obese with orlistat were impossible to estimate accurately.


Secondary information

Type
Written question
Reference
155653; 365 c758W
Session
2000-01
Subjects
Cost effectiveness Finance NHS Prescription drugs Obesity National Institute for Clinical Excellence Orlistat
Link
View this Written question on www.publications.parliament.uk